Conference Information

welcome Message

Greetings!!

We extend our warmest welcome to all attendees of the 7th European Congress on Immunology, Allergy and Vaccination, scheduled to take place on November 16–17, 2026, in London, UK.

We are delighted to host this prestigious event, which provides an opportunity for insightful discussions, collaborative networking, and innovative research presentations.

The aim of Immunology 2026 is to create an environment that encourages learning, collaboration, and the dissemination of ground-breaking ideas in an atmosphere that is stimulating and enriching.

Immunology 2026 is expected to bring together academic researchers, immunologists, allergists, clinicians, healthcare professionals, delegates, entrepreneurs and industrialists from around the world to exchange and share the latest developments, innovations and advanced research in immunology, while fostering global partnerships for future collaborative efforts.

We look forward to welcoming you and your valuable contribution to the success of this conference.

About the Conference

The 7th European Congress on Immunology, Allergy and Vaccination will be held on November 16–17, 2026, in London, UK.

The Immunology 2026 congress will be centered on the theme "Advancing Immunity: Innovations in Allergy Research and Vaccine Development."

The forthcoming Immunology 2026 conference promises an exceptional scientific experience, serving as a global platform to showcase the latest breakthroughs, emerging trends and cutting-edge research in Allergy and Vaccination.

Benefits of Attending This Conference

Connect with researchers and build new collaborations.
Present your research and gain recognition.
Network with professionals from academia and industry.
Discover emerging technologies and innovations.
Receive a certificate of participation to enhance your professional profile.

Why Attend?

Enhance your knowledge and clinical practice in vaccination through expert-led keynote lectures, scientific sessions, and evidence-based discussions.
Discover the latest research, connect with experts, and gain valuable insights to support your future projects.
Gain exposure to the latest advances in immunology and precision medicine, broadening your expertise and improving patient care through emerging scientific approaches.

Young Researchers Opportunity

Establishing their academic and professional relationships.
Interacting with expertise in their respective departments.
Clearing your inhibitions of adjusting to the foreign environment.
Providing a holistic experience of academic tourism.

List of honors given to attendees

Best Organizing Committee Member Award
Best Keynote Speaker Award
Best Speaker Award
Best Poster Award
Young Scientist Award
Best Oral Presentation Award

Scientific Sessions

Session 1: Immunology

This core session talks about the latest advancements, research discoveries, and clinical innovations in Immunology and immune system science. The program addresses immune responses, autoimmune disorders, immunotherapy, vaccine and advanced diagnostic technologies improving global healthcare and disease prevention.

Modern immunological research continues to transform disease diagnosis, treatment strategies, and patient care worldwide.

Sub-sessions:

1.1 Immune system mechanisms

1.2 Clinical immunology

1.3 Autoimmune disorders

1.4 Immunotherapy advancements

1.5 Vaccine and immune research

Related Conference

Related Journals

Session 2: Allergy

This scientific session explores the latest advances in allergy research, immune hypersensitivity, and allergic disease management at Immunology 2026. Discussions will cover allergic mechanisms, environmental and genetic risk factors, diagnostic innovations, immunotherapy and precision medicine approaches that improve patient care and long-term disease management. The session also highlights emerging strategies for allergy prevention and advances in clinical allergy research.

Connect with leading researchers and healthcare professionals to explore recent discoveries and innovative approaches shaping the future of Allergy research at Immunology 2026.

Sub-sessions:

2.1 Allergic Disorders
2.2 Immune Hypersensitivity
2.3 Food & Drug Allergies
2.4 Respiratory Allergies
2.5 Allergy Diagnostics

Related Conference

Related Associations & Societies

European Federation of Immunological Societies | American Association of Immunologists | European Academy of Allergy and Clinical Immunology | World Allergy Organization | International Union of Immunological Societies | British Society for Immunology | American Academy of Allergy, Asthma & Immunology | European Society of Clinical Microbiology and Infectious Diseases | Infectious Diseases Society of America

Session 3: Vaccine Research and Development

At Immunology 2026, this session evaluates modern advancements in vaccine research, development technologies, and immunization strategies for infectious and chronic diseases. The discussion includes clinical trials, vaccine safety, mRNA platforms, and innovative approaches improving global disease prevention.

Advanced vaccine technologies and AI-driven research continue to accelerate the development of safer and more effective vaccines worldwide.

Promotes global collaboration in vaccine innovation and public health protection.

Sub-sessions:

3.1 Vaccine discovery

3.2 Clinical trials and safety

3.3 mRNA vaccine technology

3.4 AI in vaccine research

Related Conference

Related Journals

Session 4: Virology and Viral Infections

Virology provides essential insights into the biology, diagnosis, prevention, and management of viral diseases affecting global health. This session at Immunology 2026 highlights emerging viral infections, host–virus interactions, molecular diagnostics, antiviral therapies, vaccine development and innovative research that contribute to evidence-based practice, translational science and improved patient outcomes.

Modern antiviral therapies and innovative vaccine technologies continue to improve immunization, disease prevention, disease control, and patient outcomes worldwide.

Encourages scientific collaboration and innovation in viral disease research and global healthcare protection.

Sub-sessions:

4.1 Emerging viral diseases

4.2 Viral transmission and prevention

4.3 Antiviral therapies

4.4 Vaccine technologies

Related Conference

Related Associations & Societies

Session 5: Bacteriology and Antimicrobial Resistance

This session focuses on cutting-edge developments in Bacteriology, antimicrobial resistance (AMR), and host immune responses to bacterial pathogens at Immunology 2026. Discussions will highlight bacterial pathogenesis, resistance mechanisms, innovative diagnostics, infection prevention and emerging therapeutic strategies that support improved clinical outcomes and global public health.

Encourages global collaboration in bacterial research, infection and antimicrobial management.

Sub-sessions:

5.1 Bacterial pathogenesis

5.2 Antibiotic resistance mechanisms

5.3 Infection prevention and control

5.4 Advanced antimicrobial therapies

Related Conference

Related Journals

Session 6: Emerging and Re-emerging Infectious Diseases

At Immunology 2026, this session examines newly emerging pathogens, infections, and global disease outbreak challenges. The discussion includes viral mutations, zoonotic diseases, pandemic preparedness, and advanced surveillance systems improving public health response worldwide.

Modern healthcare strategies, vaccination, and global monitoring systems continue to strengthen infectious disease prevention and outbreak control.

Encourages international collaboration in disease surveillance, research, and public health preparedness.

Sub-sessions:

6.1 Emerging viral outbreaks

6.2 Re-emerging infectious diseases

6.3 Zoonotic disease transmission

6.4 Pandemic preparedness strategies

Related Conference

Related Associations & Societies

Session 7: Immunotherapy and Precision Medicine

Immunotherapy and Precision Medicine are transforming the future of healthcare through personalized treatment strategies and targeted immune interventions. This session at Immunology 2026 highlights advances in immunotherapy, precision medicine, biomarker discovery, targeted therapies, genomic technologies, and innovative diagnostics that contribute to personalized patient care, improved clinical outcomes, and next-generation disease management.

Promotes innovation and collaboration in personalized healthcare and advanced therapeutic research.

Sub-sessions:

7.1 Targeted immune therapies

7.2 Personalized medicine approaches

7.3 Cancer immunotherapy

7.4 Biomarkers and diagnostics

7.5 Advanced therapeutic innovations

Related Conference

Related Journals

Session 8: Autoimmune and Inflammatory Disorders

Autoimmune Diseases and Inflammation examine the complex interactions between immune system dysfunction, chronic inflammatory disorders, and human health. This session at Immunology 2026 highlights autoimmune mechanisms, inflammatory pathways, advanced diagnostics, targeted therapies, biomarker research, and innovative treatment strategies that contribute to improved disease management, personalized care, and better patient outcomes.

Modern immunological and biologic therapies continue to enhance treatment outcomes for autoimmune and inflammatory disorders worldwide.

Sub-sessions:

8.1 Autoimmune disease mechanisms

8.2 Inflammatory disorders

8.3 Biologic therapies

8.4 Immune system regulation

Related Conference

Related Associations & Societies

Session 9: Molecular Immunology

This core session talks about molecular mechanisms of the immunity and advanced immunological research technologies. The session explores cellular signaling, immune responses, genetic and molecular diagnostics shaping modern healthcare research.

Advanced molecular studies continue to improve disease understanding, diagnostics and therapeutic innovations worldwide.

Sub-sessions:

9.1 Immune cell signaling

9.2 Molecular immune pathways

9.3 Genetic regulation

9.4 Cellular immunology

Related Conference

Related Journals

Session 10: Host–Pathogen Interactions

At Immunology 2026, this session discusses the interactions between pathogens and the human immune system. The session explores infection mechanisms, immune responses, pathogen survival strategies, and disease progression affecting global health.

Modern research in host–pathogen biology and immunology continues to support innovative therapies and disease prevention strategies worldwide.

Sub-sessions:

10.1 Pathogen invasion mechanisms

10.2 Immune response pathways

10.3 Viral and bacterial interactions

10.4 Disease progression studies

Related Conference

Related Associations & Societies

Session 11: Public Health and Epidemiology

At Immunology 2026, This scientific track investigates public health strategies, epidemiological research, and disease prevention approaches improving global healthcare systems. The session explores outbreak monitoring, health policies, vaccination and community health management.

Advanced epidemiological tools and healthcare strategies continue to strengthen global disease prevention and public safety.

Sub-sessions:

11.1 Disease surveillance

11.2 Public health policies

11.3 Epidemiological research

11.4 Vaccination programs

Related Conference

Related Associations & Societies

Session 12: Pandemic Preparedness and Disease Prevention

At Immunology 2026, Interactive discussions focus on pandemic preparedness, outbreak response systems, and disease prevention strategies. The session explores global healthcare readiness, infection control, emergency response planning, and vaccination approaches.

Modern preparedness programs and prevention technologies continue to improve global healthcare protection and outbreak management.

Sub-sessions:

12.1 Pandemic response planning

12.2 Infection prevention strategies

12.3 Global health preparedness

12.4 Emergency healthcare systems

Related Conference

Related Journals

Session 13: Clinical Microbiology and Diagnostics

This core session talks about presents clinical microbiology, laboratory diagnostics, and advanced disease detection technologies. The program Immunology 2026 address microbial identification, molecular diagnostics, rapid testing, and innovative laboratory techniques improving patient care.

Advanced diagnostic technologies continue to enhance early disease detection, immunology, and treatment outcomes worldwide.

Sub-sessions:

13.1 Clinical microbiology research

13.2 Molecular diagnostics

13.3 Rapid testing technologies

13.4 Laboratory innovations

Related Conference

Related Associations & Societies

Session 14: Artificial Intelligence in Healthcare

At Immunology 2026, this dedicated track covers his session presents the role of artificial intelligence in modern healthcare and infectious disease management. The program address AI-driven diagnostics, predictive analytics, digital healthcare systems and smart medical technologies improving patient outcomes.

Artificial intelligence continues to transform healthcare research, diagnostics, and clinical decision-making worldwide.

Sub-sessions:

14.1 AI in disease diagnostics

14.2 Predictive healthcare analytics

14.3 Digital healthcare systems

14.4 Smart medical technologies

Related Conference

Related Associations & Societies

Session 15: Pediatric Infectious Diseases

Pediatric Infectious Diseases focus on the prevention, diagnosis, and management of infectious conditions affecting infants, children and adolescents. This session highlights childhood infections, pediatric immunology, vaccine-preventable diseases, emerging pathogens, advanced diagnostics, antimicrobial therapies and evidence-based clinical practices that contribute to improved child health, disease prevention and better patient outcomes.

Modern pediatric healthcare and immunization programs continue to strengthen disease prevention and child wellness globally.

Sub-sessions:

15.1 Childhood infections

15.2 Pediatric immunology

15.3 Vaccination in children

15.4 Neonatal infections

Related Conference

Related Journals

Session 16: AIDS and Sexually Transmitted Infections (STI’s)

At Immunology 2026, this session evaluates HIV/AIDS, sexually transmitted infections, and modern prevention and treatment strategies. The program address antiviral therapies, disease awareness, diagnostics, and public health approaches improving patient care and disease control.

Advanced therapies and prevention programs continue to improve global management of HIV and sexually transmitted infections.

Sub-sessions:

16.1 HIV research and therapy

16.2 STI prevention strategies

16.3 Antiviral treatments

16.4 Public health awareness

Related Conference

Related Associations & Societies

Session 17: Respiratory and Airborne Infections

This scientific track investigates respiratory infections, airborne disease transmission, and modern prevention strategies. At Immunology 2026, the session explores influenza, COVID-19, lung infections, and advanced respiratory healthcare technologies improving global disease control.

Modern diagnostics, vaccines, and respiratory care continue to strengthen infection prevention and patient management worldwide.

Sub-sessions:

17.1 Airborne disease transmission

17.2 Respiratory viral infections

17.3 COVID-19 and influenza

17.4 Pulmonary infection management

Related Conference

Related Journals

Session 18: Tropical and Parasitic Diseases

At Immunology 2026, this session evaluates tropical infections and parasitic diseases affecting global populations. The session explores malaria, dengue, vector-borne diseases, and innovative treatment and prevention approaches improving public health outcomes.

Modern research and global healthcare programs continue to strengthen tropical disease control, vaccination, and prevention strategies worldwide.

Sub-sessions:

18.1 Malaria research

18.2 Vector-borne infections

18.3 Parasitic disease management

18.4 Tropical healthcare challenges

Related Conference

Related Associations & Societies

Session 19: Fungal Infections and Mycology

Scientific discussions center on fungal infections, clinical mycology, and modern antifungal therapies. At Immunology 2026, the session explores fungal diagnostics, pathogenic fungi, immune responses, vaccination and treatment innovations to improve healthcare outcomes. Advanced mycology research continues to support better diagnosis and management of fungal diseases worldwide.

Sub-sessions:

19.1 Clinical mycology

19.2 Fungal disease diagnostics

19.3 Antifungal therapies

19.4 Pathogenic fungi research

Related Conference

Related Journals

Session 20: Cancer Immunology and Immunotherapy

At Immunology 2026, this session discusses cancer immunology, immune-based cancer treatments, and innovative immunotherapy approaches. Examines targeted therapies, tumor immunity, biomarker research, personalized cancer treatment strategies, and immunology to improve healthcare outcomes.

Modern immunotherapy continues to transform cancer treatment and improve patient outcomes worldwide.

Sub-sessions:

20.1 Tumor immunology

20.2 Cancer immunotherapy

20.3 Targeted cancer therapies

20.4 Biomarkers in oncology

20.5 Personalized cancer treatment

Related Conference

Related Associations & Societies

Session 21: Biotechnology and Biologic Therapies

At Immunology 2026, this session presents biotechnology innovations and biologic therapies advancing modern healthcare. The Showcases advances in biologic drug development, genetic engineering, therapeutic antibodies, advanced pharmaceutical technologies and healthcare.

Biotechnology continues to revolutionize disease treatment, diagnostics, and healthcare research worldwide.

Sub-sessions:

21.1 Biologic drug development

21.2 Therapeutic antibodies

21.3 Genetic engineering technologies

21.4 Advanced pharmaceutical research

21.5 Biotechnology innovations

Related Conference

Related Journals

Session 22: Infectious Diseases & Global Health

This core session explores emerging infectious diseases, global health challenges, and modern prevention strategies. The program addresses viral, bacterial, fungal, and parasitic infections affecting worldwide healthcare systems.

Advanced diagnostics, vaccination and public health approaches play a major role in improving disease prevention and patient care.

Promotes global collaboration for disease control and healthcare preparedness.

Sub-sessions:

22.1 Emerging viral infections

22.2 Antimicrobial resistance

22.3 Outbreak management

22.4 Vaccine strategies

Related Conference

Related Associations & Societies

Market Analysis

Industry Overview

The Immunology and Allergy market represents one of the fastest-growing sectors in global healthcare, driven by the increasing prevalence of infectious outbreaks, chronic immune disorders, antimicrobial resistance, and rising demand for advanced diagnostic and therapeutic solutions. Continuous advancements in immunotherapy, molecular diagnostics, vaccines and biologic drug development are transforming the healthcare landscape and improving patient outcomes worldwide.

The growing focus on precision medicine, pandemic preparedness, and rapid disease detection has significantly accelerated investments in Immunology and Allergy research. Governments, healthcare organizations, pharmaceutical companies and biotechnology industries are increasingly collaborating to strengthen healthcare systems and develop innovative solutions for global disease prevention and treatment.

Global Market Statistics

Immunology Market

The global Immunology market is valued at more than USD 123 billion and is projected to exceed USD 228 billion over the next decade, with a projected Compound Annual Growth Rate (CAGR) ranging from 8% to 12%.

Infectious Disease Market

The Infectious Disease and therapeutics market is estimated at over USD 280 billion, with strong growth expected through 2030 due to the increasing incidence of Vaccination, bacterial, fungal, and parasitic diseases worldwide.

Immunotherapy Market

The global Immunotherapy market has surpassed USD 285 billion, driven by increasing adoption of biologics, monoclonal antibodies, personalized medicine, and targeted immune therapies.

Regional Market Share

North America dominates the global market with approximately 40% market share, supported by advanced healthcare infrastructure and strong investments in biotechnology and pharmaceutical innovation.

Asia-Pacific (APAC) is the fastest-growing region due to rising healthcare awareness, expanding healthcare access, rapid urbanization, and increasing investments in countries such as India, China, and Japan.

Europe continues to experience stable growth through advancements in clinical research, vaccines and therapeutic development, and public health initiatives.

Key Growth Opportunities

Rising Demand for Advanced Diagnostics

The growing need for rapid disease detection and outbreak monitoring has increased demand for molecular diagnostics, immunoassays, PCR technologies, and point-of-care testing systems.

Vaccine Research and Development

Increased investments in vaccine innovation, mRNA technologies, and preventive healthcare continue to create major opportunities for pharmaceutical and biotechnology industries.

Growth in Immunotherapy

The development of targeted immunotherapies, monoclonal antibodies, and personalized treatment approaches is transforming the management of infectious and autoimmune diseases.

Expansion of Precision Medicine

Precision medicine and biomarker-driven therapies are enabling more accurate diagnosis, individualized treatment strategies, and improved clinical outcomes.

Public Health and Pandemic Preparedness

Global healthcare systems are strengthening disease surveillance, outbreak preparedness, allergy and infection control strategies, driving growth in public health technologies and epidemiological research.

Future Outlook

The Immunology and Infectious Diseases market is growing rapidly due to increasing healthcare investments and advancements in medical technology. Innovations in artificial intelligence, immunotherapy, vaccines, and precision medicine are improving disease diagnosis and treatment.

Rising infectious diseases and immune disorders continue to drive demand for better healthcare solutions worldwide. The market is expected to expand significantly with developments in biologic therapies and digital healthcare technologies.

Immunology and Infectious Diseases will remain essential for strengthening global health security and improving patient care in the future. Scientific Sessions Highlights

7th European Congress on
Immunology, Allergy and Vaccination

Quick Links

Theme: Advancing Immunology Through Innovation, Research, and Global Collaboration

Conference Information

welcome Message

About the Conference

Scientific Sessions

Market Analysis